Buddleja officinalis inhibits high glucose-induced matrix metalloproteinase activity in human umbilical vein endothelial cells

Phytotherapy Research

Volumn 22, Issue 12, 2008, Pages 1655-1659

  Yun, Jung Lee ^a   Dae, Gill Kang ^a   Jin, Sook Kim ^b   Ho, Sub Lee ^a  

^a Wonkwang University   (South Korea)

^b Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Buddleja officinalis; Diabetes mellitus; HUVEC; Matrix metalloproteinase; Oxidative stress; Vascular inflammation

Indexed keywords

BUDDLEJA OFFICINALIS EXTRACT; GELATINASE A; GELATINASE B; GLUCOSE; HYDROGEN PEROXIDE; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGRADATION; DIABETES MELLITUS; DOSE RESPONSE; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HERBAL MEDICINE; HUMAN; HUMAN CELL; INTROSPECTION; KOREA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; VASCULAR DISEASE;

ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; BUDDLEJA; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; HYDROGEN PEROXIDE; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEDICINE, KOREAN TRADITIONAL; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UMBILICAL VEINS;

BUDDLEJA OFFICINALIS;

EID: 57549088167     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2547     Document Type: Article

References (22)

1. Boisvert WA. 2004. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 14: 161-165.
2. Death AK, Fisher EJ, McGrath KC, Yue DK. 2003. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis. 168: 263-269.
3. Deem TL, Cook-Mills JM. 2004. Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood 104: 2385-2393.
4. Dunlop M. 2000. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 77: S3-S12.
5. Furness PN. 1997. Basement membrane synthesis and degradation. J Pathol 183: 1-3.
6. Galis ZS, Sukhova GK, Lark MW, Libby P. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94: 2493-2503.
7. Gharagozlian S, Henriksen T, Kolset SO. 2006. High glucose and Nepsilon-(carboxymethyl) lysine bovine serum albumin modulate release of matrix metalloproteinases in cultured human endothelial cells. Eur J Nutr 45: 283-290.
8. +/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol 288: F988-F996.
9. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z. 1986. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261: 2814-2818.
10. Ho FM, Liu SH, Lin WW, Liau CS. 2007. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells. J Cell Biochem 101: 442-450.
11. Houghton PJ, Mensah AY, Iessa N, Hong LY. 2003. Terpenoids in Buddleja: relevance to chemosystematics, chemical ecology and biological activity. Phytochemistry 64: 385-393.
12. Nagase H, Woessner JF. 1999. Matrix metalloproteinases. J Biol Chem 274: 21491-21494.
13. Piao MS, Kim MR, Lee DG, Park Y, Hahm KS, Moon YH, Woo ER. 2003. Antioxidative constituents from Buddleia officinalis. Arch Pharm Res 26: 453-457.
14. Qi W, Poronnik P, Young B, Jackson CJ, Field MJ, Pollock CA. 2004. Human cortical fibroblast responses to high glucose and hypoxia. Nephron Physiol 96: 121-129.
15. Qian DZ, Kato Y, Shabbeer S, Wei Y, Verheul HM, Salumbides B, Sanni T, Atadja P, Pili R. 2006. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589. Clin Cancer Res 12: 634-642.
16. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. 1996. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98: 2572-2579.
17. Roth GA, Moser B, Roth-Walter F, Giacona MB, Harja E, Papapanou PN, Schmidt AM, Lalla E. 2007. Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis 190: 271-281.
18. Shah PK, Galis ZS. 2001. Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain. Circulation 104: 1878-1880.
19. Sheng GQ, Zhang JR, Pu XP, Ma J, Li CL. 2002. Protective effect of verbascoside on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. Eur J Pharmacol 451: 119-124.
20. Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ. 2001. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Exp Nephrol 9: 249-257.
21. Winberg JO, Kolset SO, Berg E, Uhlin-Hansen L. 2000. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J Mol Biol 304: 669-680.
22. Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP. 1997. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 253: 162-168.